Skip to content
2000
Volume 18, Issue 10
  • ISSN: 1570-1786
  • E-ISSN: 1875-6255

Abstract

Tetrac, a deaminated derivative of the thyroid hormome, has received some broad interest for its ability to inhibit the spread of new blood vessels, i.e., angiogenesis. For an optimum activity, the action of the dug shall be limited at the cell surface for interaction with the integrin alpha v beta 3. This was shown to be achieved via a nanoparticle formulation that would be grafted to Tetrac phenol’s OH. While the principle of this study has been disclosed elsewhere, the broad results have never been disclosed entirely. Here all outcomes of the synthesis strategy, e.g., protection and activation steps, confirmed Triisopropylsillyl as a protective group of choice to access the nanoparticle. Catalyst assisted esterification has been probed and discussed. Then the HPLC-MS study allowed to clarify reaction conditions that could subsequently yield to the desired activated Tetrac moiety. The reaction products were all characterized by 1H and 13C-NMR.

Loading

Article metrics loading...

/content/journals/loc/10.2174/1570178617999201113151319
2021-10-01
2025-09-23
Loading full text...

Full text loading...

/content/journals/loc/10.2174/1570178617999201113151319
Loading

  • Article Type:
    Other
Keyword(s): DMAP; esterification; hormone; PLGA Nanoparticle; silylating agent; Tetrac
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test